Iminodipeptides containing C-terminal proline or hydroxyproline were determined in sera from patients with prolidase deficiency, in their mother's serum, and in the sera of unfelated controls, using liquid chromatography-mass Spectrometry with an atmospheric pressure ionization interface System. The Separation was carried out on a reversed phase column using l g/l aqueous trifluoroacetic acid-methanol (75 + 25, by vol.). The quasi-molecular ions ([M -l· H])" 1
Introduction
Prolidase (EC 3.4.13.9) deficiency is a rare autosomal recessive disease characterized by chronic ulcerative dermatitis and mental retardation (l, 2). These patients also excrete large amounts of iminodipeptides in the urine(l-3).
The iminodipeptides excreted by patients have been demonstrated by amirio acid analysis (1) (2) (3) and by isotachophoresis (4) . However, these methods are unsuitable for the exact identification of urmary iminodipeptides.
The analyses of mixtures of non-volatile compounds using liquid chromatography combined with atmospheric pressure ionization mass Spectrometry (LC-APCI-MS) has recently produced promising results in different fields (5) .
We previously reported the identification of a series of synthetic iminodipeptides containing a C-terminal proline or hydroxyproline, äs well äs various endogenous iminodipeptides, in the urine of patients with iminodipeptiduria, using LC-APCI-MS (6) .
The iminodipeptides in the sera of patients with prolidase deficiency could not be detected by scan mode, because the concentration of iminodipeptides in sera is much lower than that in urine.
The present paper describes the identification of various iminodipeptides containing C-terminal proline or hydroxyproline in the sera of patients with prolidase deficiency, in the serum of their mother, and in normal subjects, using selected ion monitoring.
Experimental

Materials
Gly-Pro, Ala-Pro, Val-Pro, Leu-Pro, Ser-Pro, Thr-Pro, Met-Pro, Pro-Pro, Pro-Hyp and Gly-Hyp were purchased from Sigma. All other chemicals were of analytical grade.
Serum samples
The samples of normal human scrum were obtained from labora-1017 personnel. The samples from patients with prolidase deficiency and their mother wcre obtained from two girls (sisters) and their mother, s reported previously (3, 4) .
Instrumentation (mass spectrometry)
The apparatus used was an Hitachi L-6200 HPLC Instrument, equipped with a 5-μπι Inertsil ODS-2 packed column (150 mm X 4.6 mm 1. D.) from Gasukuro Kogyo (Tokyo, Japan), connected to a Hitachi M80B mass spectrometer-computer System, through the APCI interface (7, 8) . The nebulizer and vaporizer temperatures were 320 and 380 °C, respectively. Analyses of Standard and serum in iminodipeptides were carried out with a mobile phase of l g/l trifluoroacetic acid-methanol (75 + 25, by vol.) at a flow-rate of 0.9 ml/min.
Preparation of samples
Six ml of 20 g/l sulphosalicylic acid were added to 2 ml of serum, stirred and centrifuged at 3000 min" 1 for 10 min. The supernatant was transferred to a column containing 10 ml of Diaion SK-1 (H + form, 100 mesh, Mitsubishi Kasei, Tokyo, Japan) and washed with 50 ml of water. The iminodipeptides were then eluted with 2 mol/1 ammonia. The eluate was evaporated to dryness in vacuo. The residue was dissolved in 0.2 ml of water, then subjected to LC-APCI-MS.
Assay of prolidase activity
Erythrocyte lysates were prepared from the heparinized blood of patients and normal volunteers according to Umemura's method (9) . A mixture containing 10 μΐ of diluted erythrocyte lysate, 10 μΐ of 10 mmol/1 MnCl 2 and 80 μΐ of 50 mmol/1 Tris-HCl (pH 7.8) was preincubated for 10 min at 37 °C, then incubated with 100 μΐ of 10 mmol/1 Substrate (X-Pro) in l mmol/1 MnCl 2 for 30 min at 37 °C. The reaction was terminated by the addition of 200 μΐ of 100 g/l trichloroacetic acid solution. After 10 min at 90 °C with Chinard's reagent (10) , which consisted of ninhydrin, phosphoric acid and acetic acid, liberated proline was estimated by spectrophotometry (wavelength 515 nm). The activity towards X-Hyp was assayed according to the method reported previously (11) .
Results and Discussion
The various iminodipeptides in the urine of patients with prolidase deficiency were easily observed by scan mode using LC-APCI-MS, but since the concentration of iminodipeptides is much lower in serum than in urine, the scan mode was of no use for the analysis of serum iminodipeptides.
Therefore, iminodipeptides were analysed in serum using selected ion monitoring which is more sensitive than the scan mode. The Standard curve for different concentrations bf GlyPro is shown in figure 5 . The slope of the curve was linear over the concentration ranges from 100 nmol to 500 nmol.
The recovery of Standard iminodipeptides after ion exchange resin treatment was approximately 94%, ranging from 80 to 103%, which indicates that the method is reliable for the measurement of iminodipeptides in biological samples. Quantification of various iminodipeptides in sera from patients with prolidase deficiency, their mother and normal subjects, based on peak areas, is shown in table 1.
The iminodipeptides containing C-terminal proline or hydroxyproline (Pro-Hyp) were increased in serum from patients with prolidase deficiency. Tab. l Concentrations of various iminodipeptides in the sera of patients with prolidase deficiency, their mother and a control (mean ± SD (n = 3), mg/1). The X-Pro dipeptides could not be detected in sera from the patients' mother and from normal subjects, but the peaks corresponding to Gly-Hyp and Pro-Hyp were detected on selected ion monitoring chromatograms ( fig. 7 ).
Serum Pro-Hyp in siblings with' prolidase deficiency was much higher than in either their mother or normal subjects.
The amounts of Gly-Hyp in serum from patients with prolidase deficiency, and of Gly-Hyp and Pro-Hyp in sera from their mother and normal subjects could not be exactly determined due to interference from other peaks.
Prolidase activities against X-Pro and X-Hyp were determined in erythrocytes from patients, their mother and normal subjects, using the method described previously (11) . The prolidase activities of patients towards GlyPro and Pro-Pro were very low compared with contröls, and the mother had approximately half äs much activity äs normal subjects, which agreed with a previous report (12) . The prolidase activities of patients and normal sufc jects towards Gly-Hyp and Pro-Hyp were much lower than those towards Gly-Pro and Pro-Pro.
In patients with prolidase deficiency there was a complete deficiency of prolidase I, which shows the highest activity towards Gly-Pro.
Prolidase II, which is active mainly against MeUPro, shows the same activity in patients äs in normal subjects.
Complete digestion of Met-Pro by prolidase II seems to be the reasori why Met-Pro cannot be detected at all in serum samples from patients with prolidase deficiency (tab. 1).
The present investigations showed the presence of serum Gly-Hyp and Pro-Hyp not only in the patients, but also in their mother and normal subjects. The concentratioii of Pro-Hyp in the serum of patients was much higher than in either their mother or contröls.
These results suggest that the mother's halved activities can hydrolyse all the iminodipeptides containing a C : ' terminal proline, which are produced by the metabolisrn of collagen, so that X-Pro cannot be detected in her urine. However, low prolidase activities towards X-Hyp in the mother and normal yolunteers were not sufficient for the hydrolysis of all the endogenous iminodipeptides containing a C-terminäl hydroxyprolin.e, so that small arnounts of unhydrolysed Gly-Hyp and Pro-Hyp are found in their urines. 
